GNCA.OQ

Chart for GNCA.OQ

About

Genocea Biosciences, Inc. is a United States-based clinical-stage company that develops T cell vaccines. The Company utilizes T cell immunity to develop the next generation of vaccines. It designs vaccines using ATLAS, its technology platform. It identifies T cell antigens to induce immune responses. Its pipeline of T cell... (more)

Overall

Beta: --
Market Cap (Mil.): 201.42
Shares Outstanding (Mil.): 17.41
Dividend: --
Yield (%): --

Financials

  GNCA.OQ Industry Sector
P/E (TTM): -- 32.84 33.70
EPS (TTM): -1.87 -- --
ROI: -72.37 18.11 17.35
ROE: -- 18.82 18.21
Search Stocks

Competitors

  Price Change
Novartis AG (NOVN.VX) CHF88.30 -0.15
Pfizer Inc. (PFE.N) $30.40 -0.18
Merck & Co., Inc. (MRK.N) $60.49 +0.18
Sanofi SA (SASY.PA) €88.76 +0.30
AstraZeneca plc (AZN.L) 4,578.50p +42.00
GlaxoSmithKline plc (GSK.L) 1,449.00p +12.50
Vical Incorporated (VICL.OQ) $1.16 --

Earnings vs. Estimates

Analyst Research Reports

Report Title Price
Provider: Reuters Investment Profile
$20.00
Provider: Thomson Reuters Stock Report
$25.00
Provider: Ford Investor Services, Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00
Provider: Zacks Investment Research Inc.
$12.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

Search Stocks